Log in
Enquire now
BenchSci

BenchSci

BenchSci is a biotechnology company with a machine learning platform for researching biological compounds. It was founded in 2015 and is located in Toronto, Canada.

OverviewStructured DataIssuesContributors

Contents

benchsci.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Drug discovery
Drug discovery
Machine learning
Machine learning
20
Loading...
Educational Technology
Educational Technology
Publishing
Publishing
Open access
Open access
Search engine (computing)
Search engine (computing)
Artificial Intelligence (AI)
Artificial Intelligence (AI)
...
Location
Toronto
Toronto
12
Canada
Canada
12
B2X
B2B
B2B
CEO
Liran Belenzon
Liran Belenzon
Founder
Elvis Mboumien Wianda
Elvis Mboumien Wianda
David Qixiang Chen
David Qixiang Chen
Liran Belenzon
Liran Belenzon
‌
Tom Leung (entrepreneur)
AngelList URL
angel.co/scinapsis
Pitchbook URL
pitchbook.com/profiles...127600-57
Accelerator
FounderFuel
FounderFuel
Accelerator Batch
‌
FounderFuel Spring 2016
Number of Employees (Ranges)
201 – 500
Email Address
mcook@benchsci.com12
Full Address
25 York St, Suite 1100, Toronto, Ontario M5J 2V5, CA12
Investors
Gradient Ventures
Gradient Ventures
500 Global
500 Global
Two Small Fish Ventures
Two Small Fish Ventures
Radical Ventures
Radical Ventures
22
Ontario Centres of Excellence
Ontario Centres of Excellence
Golden Ventures
Golden Ventures
23
Real Ventures
Real Ventures
Afore Capital
Afore Capital
...
Founded Date
2015
Total Funding Amount (USD)
93,000,000
83,290,000
Latest Funding Round Date
January 24, 2022
Competitors
‌
Openclinica
‌
Health Bi
Medrio
Medrio
Cyclica (company)
Cyclica (company)
Deep Genomics
Deep Genomics
Quertle
Quertle
‌
1DegreeBio
Latest Funding Type
Series C
Series C
Wellfound ID
scinapsis
Country
Canada
Canada
12

Other attributes

Company Operating Status
Active
Funding Round Investor
500 Global
500 Global
Latest Funding Round Amount (USD)
63,000,000
46,500,000
About

BenchSci is a Toronto-based company with a focus on developing technology with artificial intelligence so it can be used to expedite the research and discovery process for medicinal drugs. The technology is a platform that can be utilized for research purposes and can give researchers specific information on their intended experiment, thus reducing time spent on researching and planning materials.

Product

The company has two platforms: the AI-Assisted Reagent Selection and the AI-Assisted Antibody Selection. The former platform has the capability of selecting the reagents for an experiment in as little as thirty seconds, whereas traditional research would take weeks. The latter platform aids researchers with finding appropriate products for the experiments using a database of more than 10 million scientific publications. The sources have been given independent validations from organizations such as The Human Protein Atlas and Encode. The academic versions of the platforms are free to appropriate institutions and the platforms can be accessed via payment for enterprise and commercial purposes.

Company

BenchSci was founded in 2015 by Tom Leung, David Q Chen, Elvis Wianda, and Liran Belenzon. Tom Leung was researching cancer when an inappropriate antibody caused him to lose rare patient samples. He contacted machine learning and data experts David Q Chen and Elvis Wianda at the University of Toronto to find out if machine learning could help choose appropriate antibodies in the future. Liran Belenzon (now CEO) met the team at the Creative Destruction Lab and together they built, tested, and validated a solution to preclinical research waste.

The company launched commercially in July 2017 with its first application, the AI-Assisted Antibody Selection platform. BenchSci's products have been used by fifteen top twenty pharma companies and over 41,200 scientists working at more than 4,450 institutions worldwide.

BenchSci raised CAD$2.75 million in three seed rounds in 2016 and 2017, led by Golden Ventures and Real Ventures. In two Series A funding rounds, they received CAD$10.2 million (May 2nd, 2018) and CAD$6.7 million (June 26th, 2019), led by Inovia and Gradient Ventures (Google's AI fund), respectively. On February 4th, 2020 BenchSci raised USD$22 million in Series B funding, bringing its total raised to USD$45 million. The lead investor was F-Prime Capital, with participation from Northleaf Capital Partners and existing investors, including Gradient Ventures, Inovia Capital, Golden Ventures, and Real Ventures. F-Prime senior vice president Shervin Ghaemmaghami will join BenchSci’s board of directors.

On November 17th, 2021, BenchSci was named a Deloitte Technology Fast 50 Company, ranking 19th. The Deloitte Technology Fast 50 program is a Canadian technology awards program. To qualify, companies must have been in business for at least four years, have revenues of at least $5 million, be headquartered in Canada, own proprietary technology, conduct research and development activities in Canada, and invest a minimum of five percent of gross revenues in Research and Development.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

1: Welcome to BenchSci!

https://youtu.be/pv5XbfSuuq4

Web

August 30, 2019

43 Pharma Companies Using Artificial Intelligence in Drug Discovery

Simon Smith (he/him)

https://blog.benchsci.com/pharma-companies-using-artificial-intelligence-in-drug-discovery

Web

BenchSci raises $22 million for AI-powered drug discovery tools

Kyle Wiggers

https://venturebeat.com/2020/02/04/benchsci-raises-22-million-for-ai-powered-drug-discovery-tools/

Web

February 4, 2020

We Are Trying To Build The Greatest Canadian Success Story In History: BenchSci CEO | Forbes India

Karen Christensen

https://www.forbesindia.com/article/rotman/we-are-trying-to-build-the-greatest-canadian-success-story-in-history-benchsci-ceo/56349/1

Web

November 28, 2019

Welcome to the BenchSci Platform

https://youtu.be/EFaDwTtqlv4

Web

February 1, 2018

References

Find more companies like BenchSci

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.